CLRN Leadership

Clinical Director

The Central and East London Clinical Director is Professor Nick Lemoine.

Professor Nick Lemoine MD PhD FRCPath FMedSci is Director of the Institute of Cancer and the CR-UK Clinical Centre at Barts and The London School of Medicine. Previously he was Professor of Molecular Pathology at Imperial College London, where he was Director of the Cancer Research UK Molecular Oncology Unit and the first Director of the National Translational Cancer Research Centre at Hammersmith Hospital. Before that, he held academic positions at the Royal Postgraduate Medical School, London and The University of Wales College of Medicine in Cardiff. He trained in medicine at St Bartholomew's Hospital Medical College where he qualified with the University of London Gold Medal in 1983 specialising in pathology and oncology with posts in London and Cardiff.   He leads the Centre for Molecular Oncology (rated 5* in the 2001 RAE) which aims to exploit the technologies of functional genomics to develop novel approaches for diagnosis, classification and treatment of human cancers. Advances in knowledge resulting from the sequencing of the human genome and the advent of high-throughput technologies now facilitate simultaneous analysis of the activity of many genes in cells and tissues, and the challenge is to translate such molecular profiles into clinical benefit for patients.  Professor Lemoine is currently a member of the Gene Therapy Advisory Committee at the Department of Health as well as chair of the MRC Clinical Research & Career Development Panel and the Department of Health Clinician Scientist Appointments & Review Panel. He has previously chaired the MRC Stem Cell Fellowship Panel, the CR-UK Clinician Scientist and Senior Clinician Fellowship Panel and the MRC Experimental Medicine Review Panel for the Molecular & Cellular Medicine Board. He has been a long-serving member of the CR-UK Science Funding Committee, MRC Molecular & Cellular Medicine Board, CORE Scientific Advisory Board and many other scientific review committees.  He has been the Editor of the Nature Specialist Journal Gene Therapy for more than a decade, and his research into the molecular genetics of cancer and gene therapy is funded by programme grants from Cancer Research UK, Digestive Cancer Campaign and the European Union. He was elected a fellow of the Academy of Medical Sciences in 2006.

Nick is supported by Co-Director Dr Marta Buszewicz.

Core Team

The Core Team is led by Dr Delphine Purves, Senior Manager. The Lead RM&G Manager is Alastair Nicholson. An Information Manager is being appointed. The Project Manager/Administrator is Robert Carver.

Executive Group

The day to day operation of the CLRN is supported by an Executive Group, led by the CLRN Clinical Director, which has representation from primary, secondary and tertiary care and mental health.

The Executive Group consists of:

• Professor John Gribben, Director of the North East London Cancer Research Network
• Professor Graham Hitman, Director of the North East London Diabetes Research Network
• Professor David Isenberg, Representative for Tertiary Care, University College London and Arthritis Research Campaign
• Professor Michael King, Representative for Mental Health, University College London, Department of Mental Health Science
• Ms Lynis Lewis, Representative for Primary Care, The North Central London Research Consortium
• Professor David Patterson, Representative for Acute and Secondary Care, Whittington NHS Trust

The Executive Group meets on the third Thursday of every month at 8am.

Last updated: 17 November 2008